PG
CVS icon

PEAK6 Group’s CVS Health CVS Stock Holding History

PEAK6 Group’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		$32.1M Sell
498,800
-231,500
-32% -$15.3M 0.14% 119
2018
Q1 		$45.4M Buy
730,300
+272,900
+60% +$19.6M 0.2% 72
2017
Q4 		$33.2M Buy
457,400
+55,800
+14% +$4.06M 0.15% 122
2017
Q3 		$32.7M Sell
401,600
-121,700
-23% -$9.63M 0.17% 107
2017
Q2 		$42.1M Sell
523,300
-104,100
-17% -$8.22M 0.24% 59
2017
Q1 		$49.3M Buy
627,400
+398,500
+174% +$31.8M 0.41% 20
2016
Q4 		$18.1M Buy
228,900
+92,100
+67% +$7.45M 0.13% 153
2016
Q3 		$12.2M Buy
136,800
+50,700
+59% +$4.79M 0.09% 273
2016
Q2 		$8.24M Buy
86,100
+81,200
+1,657% +$8.09M 0.06% 422
2016
Q1 		$508K Sell
4,900
-69,300
-93% -$6.74M ﹤0.01% 2280
2015
Q4 		$7.25M Buy
74,200
+66,600
+876% +$6.52M 0.05% 516
2015
Q3 		$733K Buy
7,600
+1,600
+27% +$168K ﹤0.01% 2521
2015
Q2 		$629K Buy
6,000
+3,500
+140% +$358K ﹤0.01% 2525
2015
Q1 		$258K Sell
2,500
-2,400
-49% -$243K ﹤0.01% 3198
2014
Q4 		$472K Sell
4,900
-300
-6% -$26.4K ﹤0.01% 2628
2014
Q3 		$414K Buy
5,200
+4,100
+373% +$323K ﹤0.01% 2656
2014
Q2 		$83K Sell
1,100
-1,400
-56% -$106K ﹤0.01% 3821
2014
Q1 		$187K Sell
2,500
-6,300
-72% -$445K ﹤0.01% 3479
2013
Q4 		$630K Sell
8,800
-46,200
-84% -$2.97M ﹤0.01% 2474
2013
Q3 		$1.56M Sell
55,000
-70,200
-56% -$4.18M 0.01% 1760
2013
Q2 		$7.16K Buy
+125,200
New +$7.25M 0.03% 495

Other funds holding CVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Parnassus Investments
Parnassus Investments San Francisco, California $34.1B AUM 20.22% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

PEAK6 Group's CVS Position: Q2 2018 in Review

PEAK6 Group reduced its CVS Health (CVS) stake by 35% in Q2 2018, selling an estimated $4.92M and leaving 141,694 shares worth $9.12M. The position accounts for 0.04% of the portfolio, ranked #479.

PEAK6 Group first reported a position in CVS in Q4 2013 and has held it in 11 quarters since. The position peaked at $13.5M in Q1 2018. 1,572 funds tracked by Wall St. Rank hold CVS as of Q2 2018.

  • PEAK6 Group held 141,694 shares of CVS Health worth $9.12M as of Q2 2018.
  • PEAK6 Group sold 74,717 CVS Health shares in Q2 2018, an estimated $4.92M.
  • CVS Health made up 0.04% of PEAK6 Group's portfolio in Q2 2018, its #479 holding.
  • PEAK6 Group first reported a position in CVS Health in Q4 2013 and has held it in 11 quarters since.
  • PEAK6 Group's CVS Health position peaked at $13.5M in Q1 2018.
  • 1,572 funds tracked by Wall St. Rank held CVS Health as of Q2 2018.

Based on PEAK6 Group's 13F filing for Q2 2018, filed 15 Aug 2018.